Page last updated: 2024-08-22

cladribine and Mast Cell Activation Disease

cladribine has been researched along with Mast Cell Activation Disease in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amazzough, K; Barete, S; Canioni, D; Casassus, P; Chandesris, MO; Coignard-Biehler, H; Damaj, G; Dubreuil, P; Durieu, I; Elie, C; Fraitag, S; Georgin-Lavialle, S; Grosbois, B; Guillet, G; Gyan, E; Hamidou, M; Hermine, O; Hirsch, I; Kahn, JE; Larroche, C; Lhermitte, L; Limal, N; Lortholary, O; Suarez, F1
Akin, C1
Mick, AB1
Amon, U; Hartmann, K; Horny, HP; Nowak, A1
Escribano, L; Núñez, R; Orfao, A; Pérez de Oteyza, J1
Nieva, J; Saven, A1
Butterfield, JH; Hoffbrand, AV; Pardanani, A; Tefferi, A1
Pardanani, A; Tefferi, A1
Butterfield, JH; Hoagland, HC; Li, CY; Tefferi, A1

Reviews

3 review(s) available for cladribine and Mast Cell Activation Disease

ArticleYear
Mastocytosis - an update.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2010, Volume: 8, Issue:9

    Topics: Adult; Antineoplastic Agents; Biopsy; Child; Chronic Disease; Cladribine; Codon; Diagnosis, Differential; DNA Mutational Analysis; Exons; Humans; Immunologic Factors; Infant; Interferon-alpha; Mast Cells; Mastocytosis; Proto-Oncogene Proteins c-kit; Skin

2010
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology.
    Leukemia research, 2004, Volume: 28, Issue:2

    Topics: Antineoplastic Agents; Child; Cladribine; Humans; Leukocytes; Mastocytosis; Retreatment

2004
Clinical, genetic, and therapeutic insights into systemic mast cell disease.
    Current opinion in hematology, 2004, Volume: 11, Issue:1

    Topics: Adult; Benzamides; Cladribine; Humans; Imatinib Mesylate; Mast Cells; Mastocytosis; Mastocytosis, Systemic; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha

2004

Other Studies

6 other study(ies) available for cladribine and Mast Cell Activation Disease

ArticleYear
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
    Blood, 2015, Aug-20, Volume: 126, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Mastocytosis; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult

2015
Cladribine for mastocytosis: benefits and risks.
    Blood, 2015, Aug-20, Volume: 126, Issue:8

    Topics: Antineoplastic Agents; Cladribine; Female; Humans; Male; Mastocytosis

2015
Clinical Pearls.
    Optometry and vision science : official publication of the American Academy of Optometry, 2016, Volume: 93, Issue:11

    Topics: Adolescent; Adult; Cladribine; Contact Lenses; Diplopia; Exophthalmos; Eye Diseases; Eyelid Diseases; Goldenhar Syndrome; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mastocytosis; Middle Aged

2016
Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma.
    Leukemia research, 2002, Volume: 26, Issue:11

    Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mast Cells; Mastocytosis

2002
Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine.
    Leukemia research, 2004, Volume: 28, Issue:2

    Topics: Adult; Aged; Bone Marrow Examination; Cladribine; Disease-Free Survival; Drug Administration Schedule; Drug Resistance; Female; Humans; Interferon-alpha; Male; Mastocytosis; Middle Aged; Remission Induction; Treatment Outcome

2004
Treatment of systemic mast-cell disease with cladribine.
    The New England journal of medicine, 2001, Jan-25, Volume: 344, Issue:4

    Topics: Antineoplastic Agents; Cladribine; Humans; Interferon-alpha; Male; Mastocytosis; Middle Aged

2001